NGS Targeted Amplicon Sequencing for Precision Medicine Revenue and Competitors
Estimated Revenue & Valuation
- NGS Targeted Amplicon Sequencing for Precision Medicine's estimated annual revenue is currently $3.3M per year.
- NGS Targeted Amplicon Sequencing for Precision Medicine's estimated revenue per employee is $203,438
Employee Data
- NGS Targeted Amplicon Sequencing for Precision Medicine has 16 Employees.
- NGS Targeted Amplicon Sequencing for Precision Medicine grew their employee count by -6% last year.
NGS Targeted Amplicon Sequencing for Precision Medicine's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO and Co-Founder | Reveal Email/Phone |
2 | VP and Sales Manager | Reveal Email/Phone |
3 | Director R&D and Operations | Reveal Email/Phone |
4 | Sr. Director Bioinformatics | Reveal Email/Phone |
5 | Market Development Manager, US West Coast and Asia Pacific | Reveal Email/Phone |
6 | Senior Technical Applications Scientist | Reveal Email/Phone |
7 | Business Operations Specialist | Reveal Email/Phone |
8 | Clinical Molecular Pathology Bioinformatics Analyst | Reveal Email/Phone |
9 | Quality Management Specialist | Reveal Email/Phone |
10 | Staff Bioinformatics Scientist | Reveal Email/Phone |
NGS Targeted Amplicon Sequencing for Precision Medicine Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 5 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 4 | -50% | N/A | N/A |
#6 | $0.7M | 8 | 0% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 17 | 31% | N/A | N/A |
What Is NGS Targeted Amplicon Sequencing for Precision Medicine?
Headquartered in Hayward, CA, Paragon Genomics is a dynamic and growing company developing and commercializing breakthrough target enrichment solutions for Next-Generation Sequencing (NGS). We are building a team of passionate scientists, engineers and business professionals who thrive in a collaborative entrepreneurial environment. Our patented CleanPlex amplicon sequencing technology solves the urgent throughput and efficiency bottlenecks of targeted sequencing workflow and is applicable to many fast-growing markets in the genomics space. The Company was selected by a distinguished panel into the California Life Science Association F.A.S.T. Program in March 2016 and was accepted into the prestigious Stanford StartX Medicine Accelerator Program in September 2016.
keywords:N/A
N/A
Total Funding
16
Number of Employees
$3.3M
Revenue (est)
-6%
Employee Growth %
N/A
Valuation
N/A
Accelerator
NGS Targeted Amplicon Sequencing for Precision Medicine News
However, the use of proprietary next-generation sequencing solutions ... from wastewater using a targeted tiled amplicon-based sequencing...
The use of whole-genome sequencing (WGS) for bacteria, ... either done using a targeted amplicon approach that is based on marker genes (for...
Other Companies in Hayward
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $2.2M | 16 | 7% | N/A |
#2 | $5.8M | 16 | -36% | N/A |
#3 | $0.7M | 16 | 78% | N/A |
#4 | $0.6M | 16 | 7% | $10.5M |
#5 | $2.3M | 16 | 33% | N/A |